Sign In
Buy AVT
$92.93
+0 (+0%)
At Close: Jun 03, 2026
Why Avnet (AVT) is Poised to Beat Earnings Estimates Again
01:10pm, Thursday, 02'nd Jan 2025
Avnet (AVT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Avnet price target lowered to $54 from $58 at Truist
01:13pm, Monday, 16'th Dec 2024
Truist analyst William Stein lowered the firm's price target on Avnet to $54 from $58 and keeps a Hold rating on the shares. The firm reiterated a cautious semiconductor and artificial intelligence se
New Strong Sell Stocks for December 6th
04:55am, Friday, 06'th Dec 2024
AM, AVT and BMO have been added to the Zacks Rank #5 (Strong Sell) List on December 6, 2024.
Avnet (AVT) Up 0% Since Last Earnings Report: Can It Continue?
12:38pm, Friday, 29'th Nov 2024
Avnet (AVT) reported earnings 30 days ago. What's next for the stock?
Avnet to Participate in Investor Conferences in December
04:30pm, Monday, 25'th Nov 2024
PHOENIX--(BUSINESS WIRE)-- #Avnet--Avnet to participate in investor conferences in December.
Avnet Declares Regular Quarterly Dividend
08:00pm, Thursday, 21'st Nov 2024
PHOENIX--(BUSINESS WIRE)-- #Avnet--Avnet declares regular quarterly dividend.
International Markets and Avnet (AVT): A Deep Dive for Investors
10:22am, Monday, 04'th Nov 2024
Examine Avnet's (AVT) international revenue patterns and their implications on Wall Street's forecasts and the prospective trajectory of the stock.
Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz Pharma, a UK headquartered global pharmaceut
Avnet Q1 Earnings Beat: Will Strong Sales View Lift the Stock?
10:11am, Thursday, 31'st Oct 2024
AVT's Q1 results reflect continued weakness in the West and Farnell segments, which more than offsets the benefit from strong performance in Asia.
Avnet, Inc. (AVT) Q1 2025 Earnings Call Transcript
04:09pm, Wednesday, 30'th Oct 2024
Avnet, Inc. (NASDAQ:AVT ) Q1 2025 Earnings Conference Call October 30, 2024 12:00 PM ET Company Participants Joe Burke - Vice President, Treasurer & Investor Relations Phil Gallagher - Chief Executive
Here's What Key Metrics Tell Us About Avnet (AVT) Q1 Earnings
10:35am, Wednesday, 30'th Oct 2024
While the top- and bottom-line numbers for Avnet (AVT) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compare
Avnet (AVT) Q1 Earnings and Revenues Surpass Estimates
10:10am, Wednesday, 30'th Oct 2024
Avnet (AVT) came out with quarterly earnings of $0.92 per share, beating the Zacks Consensus Estimate of $0.85 per share. This compares to earnings of $1.61 per share a year ago.
European Medicines Agency Confirms Acceptance of Marketing Application for AVT03, a Proposed Biosimilar to Prolia® and Xgeva®
05:01am, Thursday, 10'th Oct 2024
Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today that the European Medicines Agency (EM
European Medicines Agency Confirms Acceptance of Marketing Application for AVT03, a Proposed Biosimilar to Prolia® and Xgeva®
05:00am, Thursday, 10'th Oct 2024
REYKJAVIK, Iceland, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide,
Avnet to Support South East Water's Mass Digital Meter Deployment
01:23am, Thursday, 12'th Sep 2024
MELBOURNE, Australia--(BUSINESS WIRE)---- $AVT #Avnet--Avnet has been awarded the contract to supply Huizhong's SCL61H-100 smart ultrasonic water meters to South East Water (SEW).
